Health

Nigeria is expecting delivery of 3.92million doses of AstraZeneca vaccine from the COVAX facility between the end of July and early August. The Executive Director of, National Primary Healthcare Development Agency, Dr. Faisal Shuaib, disclosed this at a press conference in Abuja on Monday. He said the agency has since been inundated with requests to be vaccinated, adding that in response, NPHCDA has decided to reopen vaccination for the first dose. He said, “We now have information that Nigeria will get 3.92m doses of Oxford-Astrazeneca by end of July or early August.

The Federal Government has announced plans to construct and maintain oxygen plants across the nation, in order to increase oxygen reserve capacity. This was disclosed in Abuja after the Federal Executive Council (FEC) meeting on Wednesday by the Minister of Information and Culture, Mr. Lai Muhammed.

The Federal Government has announced plans to increase the hazard allowance of N5000 for health workers by 350 and 600 percent increment for junior and senior workers respectively.

The Federal Government has announced that 27 foreigners and 62 Nigerians are wanted for flouting COVID 19 safety protocols put in place for returnees from countries with a high incidence of COVID 19.

The Nigeria Centre for Disease Control (NCDC) has yesterday disclosed that the country has recorded 40 fresh cases of coronavirus infections pushing the toll in the country to surpass 166,000 as at the time of filing this report.

The National Agency for Food and Drug Administration and Control (NAFDAC) in efforts to curb the spread of the COVID-19 pandemic has granted conditional approval for emergency purposes to the Janssen COVID-19 vaccine produced by the Johnson&Johnson (J&J) medical device company. In a statement on Tuesday in Abuja, the Director-General, NAFDAC, Dr.Mojisola Adeyeye said the approval for the Janssen vaccine was done “after a thorough evaluation” of the product, adding that the agency’s vaccine committee “concluded that the data on the vaccine were robust and met criteria for efficacy, safety and quality”.